Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ · Healthcare
Arcutis Biotherapeutics Inc. Operating Income 2020–2025
Arcutis Biotherapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Arcutis Biotherapeutics Inc. operating income for the quarter ending March 31, 2026 was -9.1 M, a 62.95% decrease year-over-year.
- Arcutis Biotherapeutics Inc. operating income for the twelve months ending March 31, 2026 was -39.7 M, a 74.82% decrease year-over-year.
- Arcutis Biotherapeutics Inc. annual operating income for 2025 was -12.2 M, a 90.48% decrease from 2024.
- Arcutis Biotherapeutics Inc. annual operating income for 2024 was -128.4 M, a 46.75% decrease from 2023.
- Arcutis Biotherapeutics Inc. annual operating income for 2023 was -241.1 M, a 20.07% decrease from 2022.
- Arcutis Biotherapeutics Inc. annual operating income for 2022 was -301.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arcutis Biotherapeutics Inc. Operating Income — FAQ
Arcutis Biotherapeutics Inc. (ARQT) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Arcutis Biotherapeutics Inc.'s operating income?
Arcutis Biotherapeutics Inc. (ARQT) reported operating income of -$12M for fiscal 2025.
Where can I see ARQT's operating income history?
The chart and table above show Arcutis Biotherapeutics Inc.'s operating income by year and by quarter, including the growth rate.